Comparison of vein valve function following pharmacomechanical thrombolysis versus simple catheter-directed thrombolysis for iliofemoral deep vein thrombosis

被引:36
|
作者
Vogel, David [1 ]
Walsh, M. Eileen [1 ]
Chen, John T. [2 ]
Comerota, Anthony J. [1 ,3 ]
机构
[1] Jobst Vasc Inst, Toledo, OH 43606 USA
[2] Bowling Green State Univ, Dept Stat, Bowling Green, OH 43403 USA
[3] Univ Michigan, Ann Arbor, MI 48109 USA
关键词
QUALITY-OF-LIFE; VENOUS THROMBOSIS; POSTTHROMBOTIC MORBIDITY;
D O I
10.1016/j.jvs.2012.02.053
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Successful catheter-directed thrombolysis (CDT) for iliofemoral deep vein thrombosis (IFDVT) reduces post-thrombotic morbidity and is a suggested treatment option by the American College of Chest Physicians for patients with IFDVT. Pharmacomechanical thrombolysis (PMT) is also suggested to shorten treatment time and reduce the dose of plasminogen activator. However, concern remains that mechanical devices might damage vein valves. The purpose of this study is to examine whether PMT adversely affects venous valve function compared to CDT alone in IFDVT patients treated with catheter-based techniques. Methods: Sixty-nine limbs in 54 patients (39 unilateral, 15 bilateral) who underwent catheter-based treatment for IFDVT form the basis of this study. Lytic success and degree of residual obstruction were analyzed by reviewing postprocedural phlebograms. All patients underwent bilateral postprocedure duplex to evaluate patency and valve function. Phlebograms and venous duplex examinations were interpreted in a blinded fashion. Limbs were analyzed based on the method of treatment: CDT alone (n = 20), PMT using rheolytic thrombolysis (n = 14), and isolated pharmacomechanical thrombolysis (n = 35). The validated outcome measures were compared between the treatment groups. Results: Sixty-nine limbs underwent CDT with or without PMT. The average patient age was 47 years (range, 16-78). Venous duplex was performed 44.4 months (mean) post-treatment. Of the limbs treated with CDT with drip technique, 65% demonstrated reflux vs 53% treated with PMT (P = .42). There was no difference in long-term valve function between patients treated with rheolytic and isolated pharmacomechanical thrombolysis. In the bilateral group, 87% (13/15) demonstrated reflux in at least one limb. In the unilateral group, 64% (25/39) had reflux in their treated limb and 36% (14/39) in their contralateral limb. There was no correlation effect of residual venous obstruction on valve function, although few patients had >50% residual obstruction. Conclusions: In patients undergoing catheter-based intervention for IFDVT, PMT does not adversely affect valve function compared with CDT alone. A higher than expected number of patients had reflux in their uninvolved limb. (J Vasc Surg 2012;56:1351-4.)
引用
收藏
页码:1351 / 1354
页数:4
相关论文
共 50 条
  • [1] Catheter-directed thrombolysis vs pharmacomechanical catheter-directed thrombolysis in acute iliofemoral deep vein thrombosis
    Tawfik, Ahmad M.
    Zaidan, Mohamed H.
    Sorour, Waleed A.
    EGYPTIAN JOURNAL OF SURGERY, 2020, 39 (01): : 228 - 238
  • [2] Comparative outcomes of catheter-directed thrombolysis versus AngioJet pharmacomechanical catheter-directed thrombolysis for treatment of acute iliofemoral deep vein thrombosis
    Kang, Tao
    Lu, Yao-Liang
    Han, Song
    Li, Xiao-Qiang
    JOURNAL OF VASCULAR SURGERY-VENOUS AND LYMPHATIC DISORDERS, 2024, 12 (01)
  • [3] Catheter-directed thrombolysis for iliofemoral deep vein thrombosis
    Saunders, J. H.
    Arya, P. H.
    Abisi, S.
    Yong, Y. P.
    MacSweeney, S.
    Braithwaite, B.
    Altaf, N.
    BRITISH JOURNAL OF SURGERY, 2013, 100 (08) : 1025 - 1029
  • [4] Pharmacomechanical Catheter-Directed Thrombolysis for Pregnancy-Related Iliofemoral Deep Vein Thrombosis
    Bloom, Allan I.
    Farkas, Adam
    Kalish, Yossi
    Elchalal, Uriel
    Spectre, Galia
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2015, 26 (07) : 992 - 1000
  • [5] Catheter-directed pharmacomechanical thrombolysis for the management of deep vein thrombosis
    Klopotowski, Mariusz
    POSTEPY W KARDIOLOGII INTERWENCYJNEJ, 2011, 7 (04): : 311 - 316
  • [6] Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis
    Vedantham, S.
    Goldhaber, S. Z.
    Julian, J. A.
    Kahn, S. R.
    Jaff, M. R.
    Cohen, D. J.
    Magnuson, E.
    Razavi, M. K.
    Comerota, A. J.
    Gornik, H. L.
    Murphy, T. P.
    Lewis, L.
    Duncan, J. R.
    Nieters, P.
    Derfler, M. C.
    Filion, M.
    Gu, C. -S.
    Kee, S.
    Schneider, J.
    Saad, N.
    Blinder, M.
    Moll, S.
    Sacks, D.
    Lin, J.
    Rundback, J.
    Garcia, M.
    Razdan, R.
    VanderWoude, E.
    Marques, V.
    Kearon, C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (23): : 2240 - 2252
  • [7] Pharmacomechanical catheter-directed thrombolysis for acute iliofemoral deep vein thrombosis: our case series
    Rabuffi, P.
    Vagnarelli, S.
    Bruni, A.
    Gallucci, M.
    Ambrogi, C.
    Passaro, G.
    Flore, R. A.
    Tondi, P.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (05) : 2244 - 2252
  • [8] Pharmacomechanical catheter-directed thrombolysis for acute iliofemoral deep vein thrombosis in a large study population
    Budak, Ali Baran
    Gunertem, Orhan Eren
    Ozisik, Kanat
    Gunaydin, Serdar
    JOURNAL OF VASCULAR SURGERY-VENOUS AND LYMPHATIC DISORDERS, 2022, 10 (04) : 818 - 825
  • [9] Catheter-Directed Thrombolysis of Iliofemoral Deep Vein Thrombosis Reduces Deep Vein Thrombosis Recurrence
    Aziz, F.
    Chen, J. T.
    Comerota, A. J.
    JOURNAL OF VASCULAR SURGERY, 2011, 53 (01) : 252 - 252
  • [10] Pharmacomechanical Thrombectomy and Catheter-Directed Thrombolysis, with or without Iliac Vein Stenting, in the Treatment of Acute Iliofemoral Deep Vein Thrombosis
    Ozcinar, Evren
    Dikmen, Nur
    Kayan, Ahmet
    Kandemir, Melisa
    Saricaoglu, Mehmet Cahit
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2024, 11 (07)